Bridget Fisher
About Bridget Fisher
Bridget Fisher is a Senior Scientist and Manager at Bristol Myers Squibb in Seattle, Washington, with extensive experience in cellular therapy and immunology.
Current Positions at Juno Therapeutics and Bristol Myers Squibb
Bridget Fisher is currently employed at Juno Therapeutics, Inc. as a Scientist in Seattle, Washington. In addition to her role at Juno Therapeutics, she also holds the position of Senior Scientist and Manager at Bristol Myers Squibb, also based in Seattle. In these roles, she continues to advance her expertise in the fields of cellular therapy and biotechnological research.
Previous Roles in Infectious Disease Research
Before her current roles, Bridget Fisher worked at the Infectious Disease Research Institute as a Clinical Immunology Scientist in 2019, spending 8 months in this position in Seattle, WA. Prior to that, she was associated with the Center for Infectious Disease Research. At the Center, she served as a Staff Scientist from 2018 to 2019 and as a Postdoctoral Researcher from 2014 to 2018 in the Greater Seattle Area.
Educational Background in Microbiology and Cellular Biology
Bridget Fisher completed her higher education at The University of Memphis, where she earned a Doctor of Philosophy (PhD) in Microbiology and Immunology between 2008 and 2013. Prior to her doctoral studies, she attended Western Kentucky University, achieving a Master's degree in Cell/Cellular and Molecular Biology from 2003 to 2007. These academic achievements laid a strong foundation for her successful career in scientific research.
Development of Novel Cell-Based Assays
Bridget Fisher has been instrumental in developing novel cell-based assays that have significantly enhanced the accuracy of cellular therapy evaluations. These advancements have had a practical impact on the field, contributing to more precise and reliable assessments in cellular therapy, a critical aspect of her work in biotechnological research.
Recognition and Contributions in the Field
Bridget Fisher has presented her research findings at the International Society for Cell & Gene Therapy (ISCT) annual conference. Her work in the field has culminated in multiple peer-reviewed articles focusing on advancements in flow cytometry techniques. She has also been recognized for her contributions, having received the 'Excellence in Research' award from the American Society of Gene & Cell Therapy (ASGCT). Additionally, she has played a pivotal role in mentoring junior scientists and interns within the domain of cellular therapy analytical development.